Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:CERU
Date4/2014
Raised$60M
Post IPO Valuation

General Information

Offices

Cambridge, USA
161 First Street
Cambridge, MA, 02142
USA

People

Co-Founder and Board of Directors
President and Chief Executive Officer
Vice President, Pharmaceutical Sciences and Manufacturing
Vice President, Research
Board Member
Board Member
Board Member
Board of Directors
Show All People

Funding

TOTAL $85.7M
FUNDING TOTAL $85.7M
Venture Round, 12/2006
Polaris Partners
$2M
Series A, 5/2007
Venrock
Polaris Partners
Lux Capital
$12.1M
Series B, 1/2008
Polaris Partners
Venrock
Lux Capital
Bessemer Venture Partners
Alexandria Real Estate Equities
$8.1M
Series B, 7/2009
Polaris Partners
Venrock
Lux Capital
Bessemer Venture Partners
$10M
Venture Round, 10/2010
$1.5M
Series C, 11/2010
Lilly Ventures
Polaris Partners
Venrock
Lux Capital
Bessemer Venture Partners
$24M
Series D, 12/2011
Polaris Partners
Venrock
Lilly Ventures
Lux Capital
Bessemer Venture Partners
$15M
Private Equity, 12/2012
$13M
DEBT TOTAL $5M
Debt, 6/2010
$5M

Tags

Cerulean Pharma

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.

Recent Milestones

Videos

Screenshots

Cerulean Pharma screenshot
Above: Cerulean
Uploaded: 12/19/09

Stock Price

Sources

  1. EDGAR [edit]
  2. Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding (ceruleanrx.com) [edit]
  3. Tempo Pharmaceuticals Closes $8 Million in Series B Funding (ceruleanrx.com) [edit]
  4. Cerulean pockets $10M as it catapults into the clinic (fiercebiotech.com) [edit]
  5. SEC (sec.gov) [edit]
  6. Cerulean Pharma raises $1.5M financing (masshightech.com) [edit]
  7. Cerulean Pharma Closes $24M Series C Financing (finsmes.com) [edit]
  8. Cerulean Pharma Closes $15m Series D Financing (finsmes.com) [edit]
  9. SEC (sec.gov) [edit]
  10. Cerulean Pharma pins down $24M in Series C funding (masshightech.com) [edit]
Edit This Page
Last Edited 4/10/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy